Therapeutic Advances in Infectious Disease : Impact Factor & More
eISSN: 2049-937XpISSN: 2049-9361
Open AccessShare this on:
Key Metrics
CiteScore 
1.5
SJR
Q4Infectious Diseases
SNIP
0.8
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Therapeutic Advances in Infectious Disease
Therapeutic Advances in Infectious Disease Journal Specifications
| Overview | |
| Publisher | SAGE PUBLICATIONS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 1500 |
| Publication Time | 9 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2013 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Therapeutic Advances in Infectious Disease ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Therapeutic Advances in Infectious Disease
Adjunctive corticosteroids in non-HIV immunocompromised patients with Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis
- 4 Aug 2026
- Therapeutic Advances in Infectious Disease
Ensitrelvir in hospitalized patients with COVID-19 who were moderately to severely immunocompromised: a single-center cohort study
- 4 Aug 2026
- Therapeutic Advances in Infectious Disease
Prevalence and determinants of dolutegravir resistance among people living with HIV with virologic failure in North-Eastern Uganda: a retrospective cross-sectional study (2022\u20132024)
- 1 Aug 2026
- Therapeutic Advances in Infectious Disease
European Society of Clinical Microbiology and Infectious Diseases Study Group for Artificial Intelligence and Digitalisation consensus statements on key aspects in the interaction of clinical microbiologists and infectious disease specialists with general-purpose large language model-based systems: project protocol
- 22 Jul 2026
- Therapeutic Advances in Infectious Disease
Magnusiomyces clavatus fungemia treated with combination antifungals including isavuconazole in an immunocompromised pediatric patient: a case report
- 22 Jul 2026
- Therapeutic Advances in Infectious Disease
Chronic Fasciola hepatica infection in a patient with cutaneous visceral loxoscelism: paediatric case report
- 22 Jul 2026
- Therapeutic Advances in Infectious Disease
Adjunctive corticosteroids in non-HIV immunocompromised patients with Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis
- 4 Aug 2026
- Therapeutic Advances in Infectious Disease
Ensitrelvir in hospitalized patients with COVID-19 who were moderately to severely immunocompromised: a single-center cohort study
- 4 Aug 2026
- Therapeutic Advances in Infectious Disease
Prevalence and determinants of dolutegravir resistance among people living with HIV with virologic failure in North-Eastern Uganda: a retrospective cross-sectional study (2022\u20132024)
- 1 Aug 2026
- Therapeutic Advances in Infectious Disease
European Society of Clinical Microbiology and Infectious Diseases Study Group for Artificial Intelligence and Digitalisation consensus statements on key aspects in the interaction of clinical microbiologists and infectious disease specialists with general-purpose large language model-based systems: project protocol
- 22 Jul 2026
- Therapeutic Advances in Infectious Disease
Magnusiomyces clavatus fungemia treated with combination antifungals including isavuconazole in an immunocompromised pediatric patient: a case report
- 22 Jul 2026
- Therapeutic Advances in Infectious Disease
Chronic Fasciola hepatica infection in a patient with cutaneous visceral loxoscelism: paediatric case report
- 22 Jul 2026
- Therapeutic Advances in Infectious Disease
FAQs on Therapeutic Advances in Infectious Disease
How long has Therapeutic Advances in Infectious Disease been actively publishing? 
What is the publishing frequency of Therapeutic Advances in Infectious Disease?
How many articles did Therapeutic Advances in Infectious Disease publish last year?
What is the eISSN & pISSN for Therapeutic Advances in Infectious Disease?
What is Citescore for Therapeutic Advances in Infectious Disease?
What is SNIP score for Therapeutic Advances in Infectious Disease?
What is the SJR for Therapeutic Advances in Infectious Disease?
Who is the publisher of Therapeutic Advances in Infectious Disease?
